Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: Differential gene expression-based connectivity mapping identified novel drug candidate and improved Temozolomide efficacy for Glioblastoma

Fig. 1

Drug classes negatively connected to the GBM signature. A Pipeline for drug discovery using connectivity mapping. B Drug classes with negative connectivity scores (> − 80). HDAC inhibitors were found to be the most enriched class. C The negatively connected drugs from CMap compared with a four-way Venn diagram. The 12 drugs negatively connected to all datasets were then studied more closely. D Top 12 drugs exhibiting negative connection with GBM signature common across the four datasets

Back to article page